Leaderboards/Erythropoietin and Anemia Treatment

Erythropoietin and Anemia Treatment

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Krzysztof Badura
Medical University of Lodz
2
Lukas Lanser
Innsbruck Medical University
3
Ahmad Qarajeh
University of Jordan
4
Carmel E. Heiland
Karolinska University Hospital
5
Bjørt K. Kragesteen
Karolinska Institutet
6
Ariana Kupai
The Ohio State University
7
Aadit P. Shah
Stanford University
8
Siddartha Pullakhandam
University of Wisconsin–Milwaukee
9
Matías Fuentealba
Buck Institute for Research on Aging
10
Baljash Cheema
Northwestern University

Papers

1
Anemia of Chronic Kidney Disease—A Narrative Review of Its Pathophysiology, Diagnosis, and Management
Biomedicines|2024
78 cit.
2
Publication in Nature Aging (2025) [34 citations, W4411036731]
Nature Aging|2025
34 cit.
3
Primary Electrical Heart Disease—Principles of Pathophysiology and Genetics
International Journal of Molecular Sciences|2024
29 cit.
4
Publication in Journal of the American College of Cardiology (2024) [27 citations, W4399721649]
Journal of the American College of Cardiology|2024
27 cit.
5
Publication in Aging Cell (2025) [15 citations, W4410840634]
Aging Cell|2025
15 cit.
6
Detection of a Single Microdose of Testosterone and Recombinant EPO in Healthy Volunteers
Drug Testing and Analysis|2025
6 cit.
7
Imbalance of Iron Availability and Demand in Patients With Acute and Chronic Heart Failure
Journal of the American Heart Association|2024
5 cit.
8
Evaluation of a single Eporatio® micro‐dose in urine and dried blood spots
Drug Testing and Analysis|2024
4 cit.
9
Prevalence of Iron Deficiency in Acute and Chronic Heart Failure According to Different Clinical Definitions
ESC Heart Failure|2025
3 cit.
10
Tissue Iron Distribution in Anemic Patients with End-Stage Kidney Disease: Results of a Pilot Study
Journal of Clinical Medicine|2024
2 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
A. A. Klein
Papworth Hospital
2
K.H.P. Yu
FibroGen (United States)
3
Joseph R. Aiello
Kidney Associates
4
Yan Zou
ShanghaiTech University
5
Nicolas Leuenberger
University Centre of Legal Medicine
6
Nicholas J Kassebaum
Institute for Health Metrics and Evaluation
7
Mahir Karakas
Universität Hamburg
8
Mingyu Liu
General Hospital of Guangzhou Military Command
9
Debra Stuart
Oklahoma State Regents for Higher Education
10
Hiroki Sekine
Yamagata University

Papers

1
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021
The Lancet Haematology|2023
666 cit.
2
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021
The Lancet Haematology|2023
551 cit.
3
Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial
The Lancet|2022
372 cit.
4
Trends in the global, regional, and national burden of oral conditions from 1990 to 2021: a systematic analysis for the Global Burden of Disease Study 2021
The Lancet|2025
278 cit.
5
Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021
The Lancet|2024
64 cit.
6
Assessment of β-cyclodextrin-immobilizing hydrolyzed polyacrylonitrile membrane for enhanced remediation of bisphenol A and tetracyclines: Adsorption and antibacterial studies
Journal of Cleaner Production|2022
30 cit.
7
Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases
Cell Death and Disease|2023
27 cit.
8
PNPO–PLP axis senses prolonged hypoxia in macrophages by regulating lysosomal activity
Nature Metabolism|2024
20 cit.
9
Prevalence, incidence, and years-lived with disability due to oral disorders in Brazil: an analysis of the Global Burden of Disease Study 2019
Revista da Sociedade Brasileira de Medicina Tropical|2022
19 cit.
10
Crosslinked polyethylenimine/polyacrylonitrile blend membrane for multifunctional adsorption of heavy metals and endocrine disrupting chemicals in solution
Journal of Molecular Liquids|2022
19 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
JJ Strain
University of Ulster
2
Piotr Ponikowski
Wroclaw Medical University
3
Anthony Cerami
Araim Pharmaceuticals (United States)
4
Pietro Ghezzi
Brighton and Sussex Medical School
5
Michael Brines
Northwell Health
6
Constance Tom Noguchi
National Institute of Diabetes and Digestive and Kidney Diseases
7
Donal Reddan
Ollscoil na Gaillimhe – University of Galway
8
Robert D. Toto
Southwestern Medical Center
9
Tomas Ganz
University of California, Los Angeles
10
Michael Chopp
Henry Ford Hospital

Papers

1
The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay
Analytical Biochemistry|1996
22.5k cit.
2
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
European Heart Journal|2012
6.9k cit.
3
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
European Journal of Heart Failure|2016
5.9k cit.
4
[2] Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration
Methods in enzymology on CD-ROM/Methods in enzymology|1999
3.9k cit.
5
Correction of Anemia with Epoetin Alfa in Chronic Kidney Disease
New England Journal of Medicine|2006
2.8k cit.
6
Shock and Tissue Injury Induced by Recombinant Human Cachectin
Science|1986
2.6k cit.
7
Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
Nature|1987
2.5k cit.
8
Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of Endotoxin
Science|1985
2.4k cit.
9
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
Journal of Clinical Investigation|2004
2.2k cit.
10
Hepcidin, a Urinary Antimicrobial Peptide Synthesized in the Liver
Journal of Biological Chemistry|2001
2.2k cit.

Reagents for Erythropoietin and Anemia Treatment

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

ACAA2 (F4Y9U) Rabbit Monoclonal Antibody

#23408$161,376
View Evidence →
Cell Signaling TechnologyEvidence 62

Phospho-Tuberin/TSC2 (Ser1387) (D2R3A) Rabbit Monoclonal Antibody

#23402$176,415
View Evidence →

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 68

Gasdermin D (E9S1X) Rabbit Monoclonal Antibody

Cited in 5 papers
#39754$175,844
View Evidence →
NovusEvidence 70

Jak2 [p Tyr1007, p Tyr1008] Antibody (1A4)

Cited in 5 papers
#NBP3-26415 (also NBP3-26415-100ul, NBP3-26415-50ul)
View Evidence →
NovusEvidence 69

Jak2 Antibody (10B6)

Cited in 5 papers
#NBP3-26187 (also NBP3-26187-100ul, NBP3-26187-50ul)
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

Thioredoxin 2 (D1C9L) Rabbit Monoclonal Antibody

Cited in 20 papers
#14907$157,348
View Evidence →
Cell Signaling TechnologyEvidence 63

HEF1/NEDD9 (2G9) Mouse Monoclonal Antibody

Cited in 11 papers
#4044$158,348
View Evidence →
Cell Signaling TechnologyEvidence 65

THEX1 Antibody

Cited in 6 papers
#4049$317
View Evidence →